Clinical trial
Levofloxacin Pharmacokinetics (PK) in the Severely Obese
NCT00176306 · Joel Thompson, PhD, Other · Completed
Key facts
| NCT number | NCT00176306 |
|---|---|
| Title | Levofloxacin Pharmacokinetics (PK) in the Severely Obese |
| Official title | Levofloxacin Pharmacokinetics in the Severely Obese |
| Lead sponsor | Joel Thompson, PhD, Other |
| Collaborators | Ortho-McNeil Pharmaceutical Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obesity, Critical Illness |
| Intervention type | Drug |
| Interventions | Levofloxacin 750 mg IV |
| Enrollment | 15 |
| Start date | Jan 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 6, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: